MedTrace Logo

Effects of Curcumin Supplementation in Patients With Chronic Kidney Disease on Peritoneal Dialysis

NCT04413266 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2023-12-14

No results posted yet for this study

Summary

The objective of this study is to assess whether supplementation with curcumin could modulate the intestinal microbiota, reducing levels of inflammatory markers of oxidative stress, uremic toxins and inflammasome, in patients with chronic kidney disease in peritoneal dialysis.

Conditions

  • Chronic Kidney Diseases
  • Peritoneal Dialysis
  • Hemodialysis

Interventions

DIETARY_SUPPLEMENT

Curcumin supplementation

The patients will receive 3 capsules per day containing 500mg of curcumin for 4 weeks

Sponsors & Collaborators

  • Universidade Federal Fluminense

    lead OTHER

Principal Investigators

  • Denise Mafra, Ph.D · Federal University Fluminense

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-10
Primary Completion
2023-10-05
Completion
2023-10-05

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04413266 on ClinicalTrials.gov